CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....
Phase 1
Harrison, New York, United States and 1 other location
ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma...
Phase 2
Commack, New York, United States and 9 other locations
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
New Haven, Connecticut, United States and 56 other locations
and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before.The researchers think that a com...
Phase 2
Harrison, New York, United States and 1 other location
is to test the effects of the study drug, ensartinib, on the patient and the cancer. Ensartinib is a new, investigational type of treatment for melanoma...
Phase 2
Harrison, New York, United States and 3 other locations
with the standard-of-care drug combination, nivolumab and relatlimab, is a safe and effective treatment for people with untreated, unresectable melanoma...
Phase 2
Hartford, Connecticut, United States and 8 other locations
study to evaluate the efficacy, safety, and tolerability of APX005M in combination with nivolumab and ipilimumab in patients with advanced melanoma...
Phase 1
New Haven, Connecticut, United States and 1 other location
This is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma...
Phase 2
New Haven, Connecticut, United States
and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...
Phase 2
New Haven, Connecticut, United States and 20 other locations
with bevacizumab in patients with untreated brain metastases from melanoma or NSCLC to determine activity and safety of the drug combination...
Phase 2
New Haven, Connecticut, United States and 1 other location
Clinical trials
Research sites
Resources
Legal